Staff Profile

I started working in Newcastle Clinical Trials Unit as Trial Administrator in December 2015 and became a Trial Manager in January 2018.

I completed a Postgraduate Diploma in Clinical Research in September 2024 and in October 2024 I will start work on a PhD in Clinical Trials Methodology as part of the AGE Research Group in the NIHR Newcastle Biomedical Research Centre.

I am Trial Manager on the REVITALiSE platform trial, which is currently in set up and will be testing treatments for sarcopenia. This also forms part of my PhD research which includes ways to increase recruitment and retention of older people to trials.

Previously I was Trial Manager on TOPSAT 2, COBALT, the BHF SENIOR-RITA Trial, HAPLO+4Kids and ENHANCE-D.

• Articles

  • Kunadian V, Mossop H, Shields C, Bardgett M, Watts P, Teare MD, Pritchard J, Adams-Hall J, Runnett C, Ripley DP, Carter J, Quigley J, Cooke J, Austin D, Murphy J, Kelly D, McGowan J, Veerasamy M, Felmeden D, Contractor H, Mutgi S, Irving J, Lindsay S, Galasko G, Lee K, Sultan A, Dastidar AG, Hussain S, Haq IUI, de Belder M, Denvir M, Flather M, Storey RF, Newby DE, Pocock SJ, Fox KAA. Invasive Treatment Strategy for Older Patients with Myocardial Infarction. New England Journal of Medicine 2024, 391(18), 1673-1684.
  • White P, Gregson B, McColl E, Brennan P, Steel A, Watts P, Wood R, Bowes C, Javadpour M, Weston A, Mitra D. Emergent aneurysm treatment compared with treatment on neurological improvement in patients with ruptured poor-grade aneurysmal subarachnoid haemorrhage: the TOPSAT2 RCT. Efficacy and Mechanism Evaluation 2021, 8(8).